Table 1 Anti-tumor efficacy of PZH on Hepa1-6 mouse liver cancer in vivo.

From: Pien Tze Huang regulates phosphorylation of metabolic enzymes in mice of hepatocellular carcinoma

Group

Dose (mg/kg × days), administration

Number

(Day 1/22)

n = 8

Body weight (g)

Mean ± SD

Tumor weight (g)

Day 1

Day 22

Mean ± SD

TGI%

Control

0 × 21, po

8/8

19.6 ± 0.6

20.9 ± 0.7

0.73 ± 0.62

NA

Sorafenib

60 × 21, po

8/8

19.7 ± 0.3

19.9 ± 0.8

0.06 ± 0.02***

92.1

PZH

26 × 21, po

8/8

19.8 ± 0.4

19.5 ± 1.7

0.30 ± 0.17*

58.4

78 × 21, po

8/8

19.9 ± 0.8

19.7 ± 1.0

0.28 ± 0.16**

62.1

234 × 21, po

8/8

19.4 ± 0.7

19.4 ± 1.2

0.24 ± 0.16**

67.8

702 × 21, po

8/8

18.7 ± 0.4

19.3 ± 1.3

0.23 ± 0.11**

68.6

  1. One-way ANOVA, compared with control group, *p < 0.05, **p < 0.01, ***p < 0.001.
  2. NA not applicable, n number of replicates, TGI tumor growth inhibition.
  3. TGI % = (1 − tumor weight of treatment group/tumor weight of control group) × 100%.